158 related articles for article (PubMed ID: 33649373)
1. Alternative splicing events implicated in carcinogenesis and prognosis of thyroid gland cancer.
Wu ZH; Tang Y; Zhou Y
Sci Rep; 2021 Mar; 11(1):4841. PubMed ID: 33649373
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.
Ye P; Yang Y; Zhang L; Zheng G
Front Oncol; 2021; 11():658262. PubMed ID: 34676158
[TBL] [Abstract][Full Text] [Related]
3. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
[TBL] [Abstract][Full Text] [Related]
5. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
Montero-Conde C; Graña-Castro O; Martín-Serrano G; Martínez-Montes ÁM; Zarzuela E; Muñoz J; Torres-Perez R; Pita G; Cordero-Barreal A; Leandro-García LJ; Letón R; López de Silanes I; Guadalix S; Pérez-Barrios A; Hawkins F; Guerrero-Álvarez A; Álvarez-Escolá C; Regojo-Zapata RM; Calsina B; Remacha L; Roldán-Romero JM; Santos M; Lanillos J; Jordá M; Riesco-Eizaguirre G; Zafon C; González-Neira A; Blasco MA; Al-Shahrour F; Rodríguez-Antona C; Cascón A; Robledo M
Int J Cancer; 2020 Jan; 146(2):521-530. PubMed ID: 31403184
[TBL] [Abstract][Full Text] [Related]
7. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
8. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic alternative splicing signatures and their clinical significance in uveal melanoma.
Zhou W; Fei P; Li J
Exp Eye Res; 2021 Aug; 209():108666. PubMed ID: 34129849
[TBL] [Abstract][Full Text] [Related]
10. Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer.
Guo LJ; Zhang S; Gao B; Jiang Y; Zhang XH; Tian WG; Hao S; Zhao JJ; Zhang G; Hu CY; Yan J; Luo DL
Exp Mol Pathol; 2017 Jun; 102(3):500-504. PubMed ID: 28506768
[TBL] [Abstract][Full Text] [Related]
11. Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer.
Shi JY; Bi YY; Yu BF; Wang QF; Teng D; Wu DN
Front Oncol; 2021; 11():583547. PubMed ID: 33996533
[TBL] [Abstract][Full Text] [Related]
12. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
[No Abstract] [Full Text] [Related]
13. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of CCNE2 protein and mRNA expression in thyroid cancer tissues.
Liu CZ; Guo WP; Peng JB; Chen G; Lin P; Huang XL; Liu XF; Yang H; He Y; Pang YY; Ma W
Adv Med Sci; 2020 Sep; 65(2):442-456. PubMed ID: 33059229
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing events are prognostic in hepatocellular carcinoma.
Chen QF; Li W; Wu P; Shen L; Huang ZL
Aging (Albany NY); 2019 Jul; 11(13):4720-4735. PubMed ID: 31301224
[TBL] [Abstract][Full Text] [Related]
16. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis.
Lin P; He RQ; Huang ZG; Zhang R; Wu HY; Shi L; Li XJ; Li Q; Chen G; Yang H; He Y
Aging (Albany NY); 2019 Apr; 11(7):2082-2097. PubMed ID: 30986203
[TBL] [Abstract][Full Text] [Related]
17. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS
Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810
[TBL] [Abstract][Full Text] [Related]
18. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
19. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
Lu J; Wei S; Lou J; Yin S; Zhou L; Zhang W; Zheng S
Med Sci Monit; 2020 Jul; 26():e925733. PubMed ID: 32706768
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
